SCHEDULE: Vanguard Group Adjusts Genpact Ltd Beneficial Ownership Reporting
Beneficial Ownership Report
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Genpact Ltd following an internal realignment.
Summary
- The Vanguard Group filed an Amendment No. 8 to Schedule 13G for Genpact Ltd.
- The filing indicates that The Vanguard Group now beneficially owns 0% of Genpact Ltd's Common Stock.
- This change is due to an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis).
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
- This reporting change is in accordance with SEC Release No. 34-39538 (January 12, 1998).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It is an administrative update regarding The Vanguard Group's internal reporting structure and does not reflect a change in investment sentiment towards Genpact Ltd itself.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors holding more than 5% of a company's stock, or for those whose holdings change significantly. This particular filing reflects an administrative change in how The Vanguard Group reports its holdings, rather than a direct investment or divestment decision related to Genpact Ltd's performance. Such internal realignments are common for large asset managers to optimize reporting structures.
Key Dates
| Date | Description |
|---|---|
| 1998-01-12 | Date of SEC Release No. 34-39538, which governs certain beneficial ownership reporting. |
| 2026-01-12 | Date of internal realignment within The Vanguard Group, Inc. |
| 2026-03-13 | Date of event which requires filing of this statement (Date of Event). |
| 2026-03-26 | Date the Schedule 13G/A was signed by The Vanguard Group. |
Keywords
Schedule 13G, Vanguard Group, Genpact Ltd, Beneficial Ownership, SEC Filing, Common Stock, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.